Purchase Order 75N93023P01391

Award Date 9/27/23
Potential Completion Date 12/27/23
Potential Value $551K
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $719,435 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the delivery of one BD FACSymphony S6 Cell Sorter system. The system will meet requirements specified in the solicitation including the ability to simultaneously detect 50 parameters and sort clustered cell populations. It will be...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $350,552.50 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a BD FACSymphony A3 Special Order System. The solicitation sought a BD FACSymphony A3 Cell Analyzer and associated equipment to support the Laboratory of Immunoregulation's research on HIV/AIDS and COVID-19. No set aside was designated for this sole source requirement to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $699,900 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a BD FACSymphony S6 Special Order Cell Sorter System and related supplies. The sole source award was made pursuant to Federal Acquisition Regulation parts 12 and 13 for commercial items and simplified acquisitions to fulfill the...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for one BD FACSymphony A3 Cell Analyzer with 5 laser configurations valued at $327,752.50. This equipment will replace an existing BD LSRII flow cytometer to support ongoing research projects at the NIAID Laboratory of Immune System Biology. The contract was awarded on...
The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $335,730.01 firm fixed price purchase order to Becton, Dickinson and Company for one BD FACSymphony A3 Flow Cytometer and FACSFlow Supply System. The place of performance will be Becton, Dickinson and Company's Franklin Lakes, New Jersey facility and the period of performance is from September 20, 2022 through February 24,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Becton, Dickinson and Company (BD) for the supply of one FACSymphony A5 SORP & Fortessa System cell analyzer, valued at $574,988.05. The contract has no set-aside designation. BD is a global medical technology company that provides a wide range of equipment, reagents, and services to support biomedical research...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $776,765.60 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD Biosciences FACSDISCOVER 8S Cell Sorter instrument. Performance will take place in San Jose, California over a period of approximately two months from September 2023 through November 2023. BD Biosciences...
The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), Flow Cytometry Core Facility (FCC) awarded a $4,078,219.52 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) to acquire eight cell analyzers. The cell analyzers are needed to maintain continuity of science, data integrity, and experimental compatibility between existing equipment and critical protocols at the NIH Bethesda campus. The requirement was competed as a brand name or...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $35,187.48 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for an annual service agreement for its LSR Fortessa instrument and FACS flow cytometry system. The period of performance is from September 20, 2023 through September 19, 2024 and all work will take place in Bethesda, Maryland. No set...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $689,942.23 firm-fixed-price purchase order to Becton, Dickinson and Company's IDS division, doing business as BD Diagnostic System, for a BD FACSymphony System. The contract was awarded on September 18, 2018, with a completion date of September 28, 2018. This appears to be a stand-alone purchase order, as no set-aside was used. Becton, Dickinson is a global...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $550,885.74 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the purchase of one BD FACSymphony A5 SE Cell Analyzer system. The system will include the components listed in the attached bill of materials to the original solicitation and must meet technical requirements to detect up to 60 fluorescence parameters. Delivery of the cell analyzer is required by December 27, 2023 to the Vaccine Research Center in Bethesda, Maryland for use in its research programs. There are no set aside designations or reported major subcontractors associated with this acquisition, which has a period of performance from September 27, 2023 through delivery by late December 2023.

Generated 12/29/23, 3:08 PM